Hooper Holmes (HH) 0.53 $HH
Mark Emkjer Appointed to the Board of Directors of Hooper Holmes
Business Wire - Thu Feb 05, 8:00AM CST
Hooper Holmes (NYSE MKT: HH) has appointed Mark J. Emkjer, a senior healthcare executive with over 30 years of experience in the provider, health plan and life sciences sectors, to the Company's Board of Directors effective February 1, 2015.
HH: 0.53 (-0.01)
Hooper Holmes Appoints Dr. Neil Gordon Corporate Medical Director
Business Wire - Mon Feb 02, 8:00AM CST
Hooper Holmes (NYSE MKT:HH) has appointed a medical director with deep experience in evidence-based wellness programs to expand the Company's biometric screening capabilities and develop new services.
HH: 0.53 (-0.01)
United States Medical Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lncwzs/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical Laboratories Industry (U.S.) to reach $218.2 billion by 2021. - Medical Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - Medytox Solutions Inc - NeoGenomics Inc - Psychemedics Corporation - Quest Diagnostics Inc For more information visit http://www.researchandmarkets.com/research/lncwzs/medical Source: Plunkett Research Ltd
PMD: 15.06 (-0.37), HH: 0.53 (-0.01), BRLI: 34.10 (-0.41), NEO: 4.96 (+0.02), DGX: 76.74 (+0.56), LH: 126.80 (+0.54), GHDX: 32.14 (-0.66)
United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.53 (-0.01), BRLI: 34.10 (-0.41), RDNT: 7.54 (-0.09), NEO: 4.96 (+0.02), DGX: 76.74 (+0.56), LH: 126.80 (+0.54), GHDX: 32.14 (-0.66)
Hooper Holmes ups revenues 52% in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:59AM CST
HH: 0.53 (-0.01)
Hooper Holmes (HH) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 9:50AM CST
HH: 0.53 (-0.01)
Hooper Holmes EPS of $0
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:40AM CST
HH: 0.53 (-0.01)
Hooper Holmes Announces Third Quarter 2014 Results
Business Wire - Thu Nov 13, 6:30AM CST
Hooper Holmes (NYSE MKT:HH) today announced financial results for the third quarter ended September 30, 2014.
HH: 0.53 (-0.01)
Hooper Holmes Announces 2014 Third-Quarter Earnings Release Date and Conference Call Information
Business Wire - Fri Nov 07, 7:00AM CST
Hooper Holmes (NYSE MKT: HH) today announced that it will release 2014 third-quarter financial results before the market opens on Thursday, November 13, 2014. The Company will host a conference call on Thursday, November 13, 2014 at 7:30 a.m. CT (8:30 a.m. ET).
HH: 0.53 (-0.01)
Wall Street Breakfast: Alibaba, Apple Hint At Payment Partnership
Wall Street Breakfast - Seeking Alpha - Tue Oct 28, 5:32AM CDT
Economy World stocks inched up and U.S. bond yields steadied after almost three weeks of gains this morning with the Fed expected to announce the completion of its quantitative easing program. The Fed kicks off a two-day meeting later with...
KSS: 75.64 (+0.03), HH: 0.53 (-0.01), BX: 38.69 (unch), UBS: 18.70 (+0.56), GOOG: 560.36 (+2.37), RAD: 8.05 (-0.18), MSG: 79.85 (+0.52), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), AMD: 2.80 (+0.06), CVS: 103.86 (+0.52), GOOGL: 564.95 (+1.28), TAL: 42.18 (+0.78), SPCB: 9.06 (+0.47), TWTR: 48.44 (+0.51), AAPL: 125.90 (-1.60), BABA: 85.20 (-0.54)
Hooper Holmes: A Fast-Growing, Health And Wellness Pure-Play With Significant Upside
Acme Capital - at Seeking Alpha - Tue Oct 28, 4:00AM CDT
HH: 0.53 (-0.01)
Today In SA PRO: Monday, October 27
SA PRO Top Ideas - Seeking Alpha - Tue Oct 28, 4:00AM CDT
Top Idea: SuperCom by Dane Capital Management, LLC: Long / Micro-Cap / Electronic Equipment / Value / Earnings / Lagging Market Sentiment / Buyside Author / 80% Upside Top Idea: Hooper Holmes by Acme Capital: Long / Micro-Cap / Specialized...
PTSI: 57.32 (+1.74), HH: 0.53 (-0.01), VDSI: 23.13 (-1.57), OSTK: 23.38 (-0.29), SPCB: 9.06 (+0.47), FL: 62.70 (+0.62)
Hooper Holmes and Clinical Reference Laboratory, Inc. Launch Strategic Alliance
Business Wire - Tue Sep 02, 6:15AM CDT
--Hooper Holmes Joins CRL's Preferred Provider Network for Wellness Programs
HH: 0.53 (-0.01)
Hooper Holmes Announces Second Quarter 2014 Results
Business Wire - Tue Aug 12, 6:30AM CDT
Hooper Holmes (NYSE MKT:HH) today announced financial results for the second quarter ended June 30, 2014.
HH: 0.53 (-0.01)
Hooper Holmes Announces 2014 Second-Quarter Earnings Release Date and Conference Call Information
Business Wire - Tue Aug 05, 7:01AM CDT
Hooper Holmes (NYSE MKT: HH) today announced that it will release 2014 second-quarter financial results before the market opens on Tuesday, August 12, 2014. The Company will host a conference call on Tuesday, August 12, 2014 at 7:30 a.m. CT (8:30 a.m. ET).
HH: 0.53 (-0.01)
What Fourth Of July Weekend Will Cost You
at The Street - Thu Jul 03, 7:30AM CDT
Gas prices, hotel rates, travel and holiday spending is all up as Independence Day tacks extra time onto most workers' weekends. Even keeping it local is no bargain.
HH: 0.53 (-0.01), HTZ: 21.68 (+0.08), TRIP: 86.35 (+2.55), REG: 69.90 (+2.17), CAR: 58.88 (-0.05), MAR: 84.04 (-0.27), OWW: 11.77 (-0.02), PCLN: 1,179.17 (+2.85)
Mark Emkjer Appointed to the Board of Directors of Hooper Holmes
Business Wire - Thu Feb 05, 8:00AM CST
Hooper Holmes (NYSE MKT: HH) has appointed Mark J. Emkjer, a senior healthcare executive with over 30 years of experience in the provider, health plan and life sciences sectors, to the Company's Board of Directors effective February 1, 2015.
HH: 0.53 (-0.01)
Hooper Holmes Appoints Dr. Neil Gordon Corporate Medical Director
Business Wire - Mon Feb 02, 8:00AM CST
Hooper Holmes (NYSE MKT:HH) has appointed a medical director with deep experience in evidence-based wellness programs to expand the Company's biometric screening capabilities and develop new services.
HH: 0.53 (-0.01)
United States Medical Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lncwzs/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical Laboratories Industry (U.S.) to reach $218.2 billion by 2021. - Medical Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - Medytox Solutions Inc - NeoGenomics Inc - Psychemedics Corporation - Quest Diagnostics Inc For more information visit http://www.researchandmarkets.com/research/lncwzs/medical Source: Plunkett Research Ltd
PMD: 15.06 (-0.37), HH: 0.53 (-0.01), BRLI: 34.10 (-0.41), NEO: 4.96 (+0.02), DGX: 76.74 (+0.56), LH: 126.80 (+0.54), GHDX: 32.14 (-0.66)
United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.53 (-0.01), BRLI: 34.10 (-0.41), RDNT: 7.54 (-0.09), NEO: 4.96 (+0.02), DGX: 76.74 (+0.56), LH: 126.80 (+0.54), GHDX: 32.14 (-0.66)
Hooper Holmes ups revenues 52% in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:59AM CST
HH: 0.53 (-0.01)
Hooper Holmes (HH) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 9:50AM CST
HH: 0.53 (-0.01)
Hooper Holmes EPS of $0
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:40AM CST
HH: 0.53 (-0.01)
Hooper Holmes Announces Third Quarter 2014 Results
Business Wire - Thu Nov 13, 6:30AM CST
Hooper Holmes (NYSE MKT:HH) today announced financial results for the third quarter ended September 30, 2014.
HH: 0.53 (-0.01)
Hooper Holmes Announces 2014 Third-Quarter Earnings Release Date and Conference Call Information
Business Wire - Fri Nov 07, 7:00AM CST
Hooper Holmes (NYSE MKT: HH) today announced that it will release 2014 third-quarter financial results before the market opens on Thursday, November 13, 2014. The Company will host a conference call on Thursday, November 13, 2014 at 7:30 a.m. CT (8:30 a.m. ET).
HH: 0.53 (-0.01)
Wall Street Breakfast: Alibaba, Apple Hint At Payment Partnership
Wall Street Breakfast - Seeking Alpha - Tue Oct 28, 5:32AM CDT
Economy World stocks inched up and U.S. bond yields steadied after almost three weeks of gains this morning with the Fed expected to announce the completion of its quantitative easing program. The Fed kicks off a two-day meeting later with...
KSS: 75.64 (+0.03), HH: 0.53 (-0.01), BX: 38.69 (unch), UBS: 18.70 (+0.56), GOOG: 560.36 (+2.37), RAD: 8.05 (-0.18), MSG: 79.85 (+0.52), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), AMD: 2.80 (+0.06), CVS: 103.86 (+0.52), GOOGL: 564.95 (+1.28), TAL: 42.18 (+0.78), SPCB: 9.06 (+0.47), TWTR: 48.44 (+0.51), AAPL: 125.90 (-1.60), BABA: 85.20 (-0.54)
Hooper Holmes: A Fast-Growing, Health And Wellness Pure-Play With Significant Upside
Acme Capital - at Seeking Alpha - Tue Oct 28, 4:00AM CDT
HH: 0.53 (-0.01)
Today In SA PRO: Monday, October 27
SA PRO Top Ideas - Seeking Alpha - Tue Oct 28, 4:00AM CDT
Top Idea: SuperCom by Dane Capital Management, LLC: Long / Micro-Cap / Electronic Equipment / Value / Earnings / Lagging Market Sentiment / Buyside Author / 80% Upside Top Idea: Hooper Holmes by Acme Capital: Long / Micro-Cap / Specialized...
PTSI: 57.32 (+1.74), HH: 0.53 (-0.01), VDSI: 23.13 (-1.57), OSTK: 23.38 (-0.29), SPCB: 9.06 (+0.47), FL: 62.70 (+0.62)
Hooper Holmes and Clinical Reference Laboratory, Inc. Launch Strategic Alliance
Business Wire - Tue Sep 02, 6:15AM CDT
--Hooper Holmes Joins CRL's Preferred Provider Network for Wellness Programs
HH: 0.53 (-0.01)
Hooper Holmes Announces Second Quarter 2014 Results
Business Wire - Tue Aug 12, 6:30AM CDT
Hooper Holmes (NYSE MKT:HH) today announced financial results for the second quarter ended June 30, 2014.
HH: 0.53 (-0.01)
Hooper Holmes Announces 2014 Second-Quarter Earnings Release Date and Conference Call Information
Business Wire - Tue Aug 05, 7:01AM CDT
Hooper Holmes (NYSE MKT: HH) today announced that it will release 2014 second-quarter financial results before the market opens on Tuesday, August 12, 2014. The Company will host a conference call on Tuesday, August 12, 2014 at 7:30 a.m. CT (8:30 a.m. ET).
HH: 0.53 (-0.01)
What Fourth Of July Weekend Will Cost You
at The Street - Thu Jul 03, 7:30AM CDT
Gas prices, hotel rates, travel and holiday spending is all up as Independence Day tacks extra time onto most workers' weekends. Even keeping it local is no bargain.
HH: 0.53 (-0.01), HTZ: 21.68 (+0.08), TRIP: 86.35 (+2.55), REG: 69.90 (+2.17), CAR: 58.88 (-0.05), MAR: 84.04 (-0.27), OWW: 11.77 (-0.02), PCLN: 1,179.17 (+2.85)
